Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04696640
NCT04696640
Completed
Not Applicable

Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes

University of California, Davis1 site in 1 country39 target enrollmentJune 3, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsType 1 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 1 Diabetes
Sponsor
University of California, Davis
Enrollment
39
Locations
1
Primary Endpoint
Feasibility of remote glucose monitoring for pediatric T1D patients who receive care at UC Davis Health
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This project explores the feasibility and utility of remote glucose monitoring for a cohort of children and adolescents with type 1 diabetes (T1D) cared for at UC Davis Health (UCDH).

Registry
clinicaltrials.gov
Start Date
June 3, 2021
End Date
May 25, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Diagnoses of type 1 diabetes with a duration of greater than or equal to 12 months
  • •Use of a continuous glucose monitor (CGM) for greater than or equal to 6 months
  • •Intention to continue receiving care at the UC Davis Health Pediatric Diabetes clinic.

Exclusion Criteria

  • •Patient's CGM cannot be uploaded to Glooko

Outcomes

Primary Outcomes

Feasibility of remote glucose monitoring for pediatric T1D patients who receive care at UC Davis Health

Time Frame: 1 month baseline period

Proportion of participants who have successfully established remote glucose monitoring by the end of the baseline period.

Change in hemoglobin A1c (HbA1c)

Time Frame: Initiation = 1 month after enrollment, Study completion = 7 months after enrollment

HbA1c at study completion minus the HbA1c at initiation

Secondary Outcomes

  • Data-sharing experience survey(1 month after enrollment)
  • Remote patient monitoring survey(Month 7 after enrollment)
  • Hyperglycemic range(Months 1-7 after enrollment)
  • Hypoglycemic range(Months 1-7 after enrollment)
  • Target Glucose Range(Months 1-7 after enrollment)
  • Overall continuous glucose monitor (CGM) wear time(Months 1-7 after enrollment)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Remote Monitoring of Diabetes in Young Children With Type 1 DiabetesType 1 Diabetes Mellitus
NCT02848261Stanford University92
Withdrawn
Not Applicable
Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese WomenDiabetes, GestationalDiabetes Mellitus Type 2 Pre-Existing
NCT05453357University of Arkansas20
Completed
Phase 4
Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch BiographerDiabetes Mellitus, Insulin-Dependent
NCT00069628Jaeb Center for Health Research200
Completed
Not Applicable
Continuous Glucose Monitor in Children With Poorly Controlled DiabetesType 1 Diabetes Mellitus
NCT02530450The University of Texas Health Science Center at San Antonio30
Completed
Not Applicable
Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT PopulationHematopoietic Stem Cell Transplantation
NCT03037671University of Colorado, Denver29